Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Some people with the skin color loss condition, vitiligo, also develop the skin inflammation condition, lichen planus, possibly due to local trauma, sun damage, or genetic factors.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Alopecia areata in children is often linked to genetics, autoimmune issues, and stress, and is treated with corticoids or PUVA therapy.

The treatment helped some patients with severe hair loss regrow hair.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Combination therapies might work better for some vitiligo patients, but results vary.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Some breast cancer chemotherapy can cause permanent hair loss.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Skin grafting can help repigment vitiligo, but it's less effective for widespread cases due to the Koebner phenomenon.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.